Treatments, Nutraceuticals, Supplements and Herbal Medicine in Neurological Disorders offers readers a comprehensive reference on their potential for treatment in a wide variety of neurological diseases. Spanning various types of these compounds, this broad coverage allows readers to learn about the use of nutraceuticals and botanicals alone, or in combination with, other dietary regimes and/or vitamins and minerals. It covers diseases including Alzheimer's, Parkinson's, ALS and MS, and severe neurological conditions including brain injury, stroke, headache and migraine. This volume provides a platform for research on nutraceuticals and botanical agents and on future investigations of these compounds.
There are over 600 neurological disorders affecting both the central and peripheral nervous systems, some of which have been treated by nutraceuticals and herbal medicine, hence this is a timely resource on the topics covered.
Rezensionen / Stimmen
*4 stars* "...covers a host of neurological conditions, and provides insights, research and commentary on the conditions described and the nutraceuticals or herbs that either have been used, or may provide utility for the management of the condition. The book's purpose is to provide a reference for the potential of nutraceuticals and herbal medicine for treating neurological disorders. [A] worthy objective as this is a largely unexplored field... [It] serves as a quick reference for practitioners, describing why an herbal medicine or nutraceutical may benefit a patient... [A] comprehensive read, and as such, is best considered a necessary reference." -- (c)Doody's Review Service, 2024, Tolu Oyelowo, DC, PhD (Northwestern Health Sciences University)
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
Illustrationen
Approx. 125 illustrations (125 in full color); Illustrations
Maße
Höhe: 202 mm
Breite: 247 mm
Dicke: 61 mm
Gewicht
ISBN-13
978-0-323-90052-2 (9780323900522)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries. Dr. Patel is a Reader at the University of Westminster. After completing his PhD at King's College London, he continued his research experience by undertaking his post-doctoral studies in the laboratory of Professor Cunningham in the Department of Biochemistry at the Wake Forest University School of Medicine, (Winston-Salem, NC, USA). This extensive project involved investigating mechanisms of hepatic mitochondrial ribosome dysfunction in alcoholic liver disease (ALD) using biophysical and proteomic techniques. These studies have led to new avenues in determining the pathology of ALD. His teaching areas at both post-graduate and undergraduate levels include clinical biochemistry, investigative pathology and laboratory investigation. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King's College Hospital and Emeritus Professor of Nutritional Biochemistry at King's College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King's College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.
Herausgeber*in
Visiting Professor of Perinatal Wellbeing, Institute for Health and Wellbeing, University of Suffolk, Ipswich, UK
Reader in Clinical Biochemistry, University of Westminster, London, UK
Professor, Department of Clinical Biochemistry, King's College Hospital, London, UK; Emeritus Professor, Faculty of Life Sciences and Medicine, King's College London, UK Visiting Professor, University of Hull, UK
Preface
I. Alzheimer's Disease and Dementias
1. Guarana (Paullinia cupana Mart.) and protection against amyloid-beta toxicity: applications to Alzheimer disease and dementias
Felix Alexandre Antunes Soares
2. Herbs for Alzheimer's disease management; Clinical studies: a narrative
Narjes Gorji, Zahra Memariani and Reihaneh Moeini
3. Reducing neurodegeneration and oxidative damage in Alzheimer's disease. Role of the Nrf2 pathway activation by natural compounds
Francisca Villavicencio-Tejo and R. A. Quintanilla
4. Alzheimer's disease and green coffee bean extract
N.N. Younis and R. G. Eissa
5. Callistemon viminalis and protection in Alzheimer's disease
Y. Prashar
6. Herbs for Alzheimer's disease management; Preclinical studies: a narrative
Narjes Gorji, Reihaneh Moeini and Zahra Memariani
7. Allicin as a nutraceutical: usage in Alzheimer's disease
Shivani Chib, Bhaskar Jyoti Dutta, Sudhanshu Mallan, Khadga Raj and Shamsher Singh
II. Amyotrophic Lateral Sclerosis
8. Rutin and applications to Amyotrophic Lateral Sclerosis
Uma Maheswari Krishnan
9. Kaempferol and kaempferide and amyotrophic lateral sclerosis
E. Srinivasan, G. Chandrasekhar and R. Rajasekaran
III. Brain Injury
10. French maritime pine bark extract and neurological disorders
Abdolreza Norouzy
11. Angong Niuhuang Pill could be an Effective Medicinal Agent for Stroke Treatment
Jiangang Shen
12. Polyphenols as therapeutic interventions against cerebral ischemic injury
Uma Maheswari Krishnan
13. Da Chuanxiong formula and use in traumatic brain injury
Zhike Liu, Angela SM Hung, Erik CH KO, Johnny CM Koon and PING-CHUNG LEUNG
IV. Dietary Neurotoxins
14. Coriandrum sativum protection in mercury neurotoxicity
Barbarella Macchi, Fabio Oliveira, Moises Hamoy, Chubert Sena, Edilene Silva, Gabriela Arrifano, Maria Elena Crespo-Lopez and J.L.M. do Nascimento
15. Taurine in symptom amelioration and recovery in lead induced neurotoxicity
Lorenz Simon Neuwirth and Bright Emenike
16. Omega-3 Fatty Acid as a protectant in lead induced neurotoxicity
Rajendra. Nath
V. Epilepsy
17. Dietary flavonoids and management of epilepsy
Damanpreet Singh
18. Magnesium supplemental therapy in epileptogenesis and ictogenesis
Jimmy Li and Denahin Hinnoutondji Toffa
19. Curcumin usage in epilepsy
Deepak Sharma and Chandra Prakash
20. Triheptanoin as a nutraceutical and potential use in epilepsy
Giovanna Testa, Mario Costa and Marco Mainardi
VI. Headaches and Migraines
21. Dietary supplementation in migraine: a focus on omega-3 fatty acids
Fahimeh Martami and Sakineh Shab-bidar
22. Headaches, migraine and herbal medicine
Ching-Liang Hsieh
23. Magnesium and migraine
Lidia Savi
VII. Multiple Sclerosis
24. Betaine as a neuroprotective therapy for multiple sclerosis
Jennifer McDonough and Sarah Sternbach
25. Natural products and their bioactive compounds in Multiple Sclerosis
Jasvinder Singh Bhatti
26. The Crocin usage in Multiple sclerosis
A. Ranjbar
VIII. Neuroinflammation
27. The Potential Role of Herbal Medicine & Nutraceuticals in Neuroinflammatory Disorders: A Mechanistic Insight via Multi-Signaling Cascades
Salman Khan
28. Arbutin as a natural soluble glycosylated phenol and usage in neuroinflammation
Maryam Ghasemi-Kasman, Hanie Yavarpour-Bali and Sadaf Abdi
29. Plant-based oils used to treat neuroinflammation
Priya Madhavan and Shantini Vijayabalan
30. Clinacanthus nutans leaf' anti-neuroinflammatory potentials
Intan S. Ismail and Amalina Ahmad Azam
31. Nutraceuticals and bioactive components of herbal extract in the treatment and prevention of neurological disorders
Chandana Choudhury Barua
32. Effect of tinospora cordifolia on neuroinflammation
Vipin V. Dhote, Mohan Raja, Aman B. Upaganlawar, Vaishali Kilor, Ashish Singhai and Avinash Singh Mandloi
33. Neuroprotective potential of quercetin as a nutraceutical targeting fused neuroinflammation in neurological disease
Ayansh Kaushik, Kanupriya Chauhan and Shamsher Singh
IX. Parkinson's Disease
34. Pre and Probiotics and Parkinson's Disease
Reza Amani and Sanaz Mehrabani
35. Omega 3 polyunsaturated fatty acids and its use in Parkinson disease
Abril Ramirez-Higuera, Carolina Pena-Montes, Alejandra Barroso-Hernandez, Oscar Lopez-Franco and Rosa Maria Oliart-Ros
36. The flavone chrysin and usage in Parkinson's Disease
Ankita Murmu, Alagudurai Krishnamoorthy and Murugan Sevanan
37. Blackberry (Morus nigra) and usage in Parkinson's Disease
Yasir Hasan Siddique, Gulshan Ara and Falaq Naz
X. Peripheral Neuropathy
38. Use of coumarin osthole in peripheral neuropathy
Rajbir Bhatti and Lovedeep Singh
39. Therapeutic Benefits of Phenolic Acids in Peripheral Neuropathy
Shubhangi Hemraj Pawar
40. Resveratrol as a potential therapeutic molecule against neuropathy- a new narrative
Irshad Ahmad, Rukkumani Rajagopalan, ABHIJIT DEY and Muddasarul Hoda
41. Effect of kaempferol and use in peripheral neuropathy
Prerna Sharma, Aishwarya Gangwar, Nidhi Rani and Randhir Dahiya
42. Cleistocalyx nervosum var. paniala fruit on neuropathy
Wathita Phachonpai
XI. Prenatal Effects and Neurodevelopment
43. Nutritional supplementation for the prevention and treatment of neonatal brain injury: Breast milk and beyond
Myrna Brandt, Cora Nijboer, Ruurd van Elburg, Manon J. N. L. Benders and Caroline Gillis Marleen de Theije
44. Maternal naringenin supplementation during pregnancy disrupts the redox status in the developing rats' brain
Bernardo Gindri dos Santos, Pauline Maciel August and Cristiane Matte
45. Tryptophan as a supplement in cerebral palsy
Diego Lacerda, Diego Visco and A. E. Toscano
46. Centella asiatica and protection in neurodevelopment
G. Bolumbu
XII. Stroke
47. Genistein and use in neuroprotective agent in stroke
Derek A. Schreihofer
48. Leucine-enriched amino acid supplement and use in stroke
Takashi IKEDA and Nobuo Morotomi
49. Arginine and neuroprotection: a focus on stroke
Yasutoshi Koga Sr.
50. Isoflavones as neutraceuticals in stroke: therapeutic targets and signalling pathways
M. Ram Pravin Kumar, C. Vijayalakshmi and M. Ramanathan
51. Trigonelline and uses in stroke
Pallab Bhattacharya
XIII. Resources
52. Research and Resources
Rajkumar Rajendram
